The first pill shown to treat COVID-19 has moved one step closer to being available to the public. The pharmaceutical company Merck requested FDA emergency authorization Monday for their COVID-19 ...
The FDA said Friday that Merck's anti-COVID-19 pill is effective in treating the virus but said that regulators will meet next week to investigate whether the pill is safe for people who are pregnant ...
WASHINGTON (AP) — An experimental COVID-19 drug that could soon become the first U.S.-authorized pill to treat the coronavirus faces one final hurdle Tuesday: A panel of government experts will ...
(Reuters) – The European Medicine Agency’s review to approve Merck’s antiviral pill molnupiravir, developed with Ridgeback Therapeutics, is set to conclude by the end of the year, the regulator’s head ...
The Biden administration has confirmed that pharmaceutical company Merck will partner with one of its rivals, Johnson & Johnson, in order to speed up the production of J&J’s newly-approved COVID-19 ...
Countries are scrambling to buy the antiviral pills developed by Merck and Pfizer for adult COVID-19 patients. Healthcare & Pharmaceuticalscategory· January 20, 2022 Dozens of firms to make cheap ...
Partisan divides shape our thinking about vaccines, new data shows. But it's more complicated than it seems. When it comes to COVID-19 vaccines specifically, 83% of Republicans say they don't want the ...
Sept 11 (Reuters) - U.S. drugmaker Merck & Co Inc (MRK.N), opens new tab has begun recruiting participants to its early-stage COVID-19 vaccine study, according to the government database ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results